158 POSTER Abiraterone acetate (AA), an irreversible inhibitor of CYP17, has significant and durable anti-tumor activity in both chemotherapy- naive and docetaxel treated castration-resistant prostate cancer (CRPC)
G. Attard, A. Reid, N. Babu Oommen, L. Folkerd, D. Olmos, E. Thompson, G. Maier, M. Dowsett, D. Dearnaley, J.S. De BonoVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72090-1
File:
PDF, 59 KB
english, 2008